Dr. Daniele Gilkes is assistant professor of oncology, as well as an assistant professor in chemical and molecular engineering at the Johns Hopkins University School of Medicine.
This is her first year as a BCRF grantee. Dr. Paul Macklin is an associate professor of intelligent systems engineering, and a member of the Melvin & Bren Simon Cancer Center at Indiana University.
He’s a BCRF grantee since 2014. Together, Drs. Gilkes and Macklin are part of a collaboration between the BCRF and JKTG Foundation that links computational scientists with biologists.
They recently talked to BCRF about their efforts to gain new insights into tumor growth, metastasis, and the mechanics of drug resistance.
Featured news
Ted’s Take: Listen to those who lived history to truly learn
There are many historians out there and they seem to get a lot of respect. They are asked about particular events or circumstances and often asked their take about what happened and when and why and how.
Ted’s Take: Getting credit is BS. Performance is the only thing that matters.
It seems many folks today, especially younger workers, want to get credit for the work they do. That’s not all bad. Maybe they are trying to get promoted earlier than others. Maybe they are trying to get ahead. But it can get in the way of one’s professional and personal development.
Ted’s Take: The other end of the field
JKTG-funded research, Iron oxide nanoparticles inhibit tumor progression and suppress lung metastases in mouse models of breast cancer, appears in the journal ACS Nano and features a collaboration between researchers at Johns Hopkins University School of Medicine and the Hormel Institute at the University of Minnesota.
Jayne Koskinas Ted Giovanis
Foundation for Health and Policy
PO Box 130
Highland, Maryland 20777
Media contact: 202.548.0133